Capitalization and Additional Issuances. The Company is authorized to issue up to 200,000,000 shares of common stock comprised of 150,000,000 shares of common stock, par value $0.001 and 50,000 shares of preferred stock, par value $0.001 of which 9,800,000 shares of common stock and zero (0) shares of preferred stock were issued and outstanding as of May 24, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock to members of its Board of Directors.
Appears in 2 contracts
Samples: Artl Subscription Agreement, Artl Subscription Agreement (Artelo Biosciences, Inc.)
Capitalization and Additional Issuances. The Company is has authorized to issue up to 200,000,000 shares of common stock comprised Common Stock. As of 150,000,000 February 14, 2013, there were 43,036,372 shares of common stock, par value $0.001 the Common Stock issued and 50,000 outstanding. All of the outstanding shares of preferred stockthe Common Stock are, par value $0.001 of which 9,800,000 shares of common stock and zero (0) shares of preferred stock were the Shares to be issued will be, duly authorized and outstanding as of May 24validly issued, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock to members of its Board of Directorsfully paid and non-assessable Common Stock.
Appears in 2 contracts
Samples: Note Subscription Agreement (Millennium Healthcare Inc.), Warrant Subscription Agreement (Millennium Healthcare Inc.)
Capitalization and Additional Issuances. The Company is has authorized to issue up to 200,000,000 shares of common stock comprised of 150,000,000 100,000,000 shares of common stock. As of October 16, par value $0.001 and 50,000 2018 there were approximately -0- shares of preferred stock, par value $0.001 the common stock issued and outstanding. All of which 9,800,000 the outstanding shares of the common stock are, and zero (0) shares of preferred stock were the Shares to be issued will be duly authorized and outstanding as of May 24validly issued, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of fully paid and non- assessable common stock to members of its Board of Directorsstock.
Appears in 2 contracts
Samples: Rchase Agreement (New World Technologies, Inc.), Common Stock Purchase Agreement (New World Technologies, Inc.)
Capitalization and Additional Issuances. The Company is has authorized to issue up to 200,000,000 shares of common stock comprised of 150,000,000 shares of common stock, par value $0.001 and 50,000 shares of preferred stock, par value $0.001 of which 9,800,000 shares of common stock and zero Five Hundred Million (0500,000,000) shares of preferred stock Common Stock. As of March 31, 2014, there were 143,804,560 shares of the Common Stock issued and outstanding. All of the outstanding as of May 24, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock the Common Stock are, and the Shares to members of its Board of Directorsbe issued pursuant to the Warrants will be, duly authorized and validly issued, fully paid and non-assessable and are not (and will not be) subject to preemptive or similar rights affecting the Common Stock.
Appears in 1 contract
Capitalization and Additional Issuances. The Company is has authorized to issue up to 200,000,000 shares of common stock comprised Common Stock. As of 150,000,000 the Closing Date, there were approximately 43,636,372 shares of common stock, par value $0.001 the Common Stock issued and 50,000 outstanding. All of the outstanding shares of preferred stockthe Common Stock are, par value $0.001 of which 9,800,000 shares of common stock and zero (0) shares of preferred stock were the Shares to be issued will be, duly authorized and outstanding as of May 24validly issued, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock to members of its Board of Directorsfully paid and non-assessable Common Stock.
Appears in 1 contract
Samples: Subscription Agreement (Millennium Healthcare Inc.)
Capitalization and Additional Issuances. The Company is has authorized to issue up to 200,000,000 shares of common stock comprised of 150,000,000 shares of common stock, par value $0.001 and 50,000 shares of preferred stock, par value $0.001 of which 9,800,000 shares of common stock and zero Two Hundred Fifty Million (0250,000,000) shares of preferred stock Common Stock. As of November 18, 2011, there were 52,292,644 shares of the Common Stock issued and outstanding. All of the outstanding as of May 24, 2017. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock the Common Stock are, and the Shares to members of its Board of Directorsbe issued pursuant to the Note and the Warrants will be, duly authorized and validly issued, fully paid and non-assessable and are not (and will not be) subject to preemptive or similar rights affecting the Common Stock.
Appears in 1 contract
Samples: Form of Subscription Agreement (Revolutions Medical CORP)
Capitalization and Additional Issuances. The Company is authorized to issue up to 200,000,000 shares of common stock comprised of 150,000,000 shares of common stock, par value $0.001 and 50,000 shares of preferred stock, par value $0.001 of which 9,800,000 12,781,195 shares of common stock and zero (0) shares of preferred stock were issued and outstanding as of May 24June 5, 20172018. The Company has agreed to issue up to an aggregate of 220,000 shares of common stock to members of its Board of Directors.ARTL SUBSCRIPTION AGREEMENT
Appears in 1 contract
Samples: Artl Subscription Agreement (Artelo Biosciences, Inc.)